Over the projected period, the addiction treatment market was expected to expand at a compound annual growth rate (CAGR) of 6.7%. Due to the expected large acceptance in commercial settings, there will be a $50 million potential over the next 10 years.
The novel coronavirus is often more likely to spread in social and communal settings when smoking equipment such as water pipes and sharing mouthpieces and hoses. Patients are at risk because illnesses that increase the body's requirement for oxygen or impair its ability to use it effectively make them more vulnerable to potentially fatal lung infections like pneumonia.
Download Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4712
Country-Wise Analysis
The United States remains the most lucrative region for the expansion of the addiction treatment market. The increasing adoption of treatment solutions, particularly for tobacco cessation, coupled with a well-established healthcare infrastructure, is driving market growth. The U.S. is expected to account for more than 40% of the global addiction treatment market, with growth projected to expand 1.4x during the forecast period.
The dominance of the U.S. market is attributed to the growing prevalence of tobacco addiction and numerous government initiatives aimed at reducing substance abuse.
For instance, data from the Centers for Disease Control and Prevention (CDC) as of December 2020 revealed that nearly 14% of U.S. adults aged 18 years and older smoked cigarettes in 2019. This equates to approximately 34.1 million adults who smoke, with around 16 million individuals suffering from smoking-related diseases and associated health complications.
Key Segments Profiled in the Addiction Treatment Industry Survey
Fact.MR has studied the global addiction treatment market with detailed segmentation on the basis of treatment type, drug type, treatment centers, distribution channel, and key regions.
-
By Treatment Type :
- Alcohol
- Tobacco/Nicotine
- Opioid
- Other Substances
-
By Drug Type :
- Bupropion
- Varenicline
- Acamprosate
- Disulfiram
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Replacement Products
- Others
-
By Treatment Centers :
- Outpatient Treatment Centers
- Residential Treatment Centers
- Inpatient Treatment Centers
-
By Distribution Channel :
- Hospital Pharmacy
- Medical Stores
- Others
-
By Key Regions :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
Comments
0 comment